DDInter1271 DDInter1180
Nebivolol is a racemic mixture of 2 enantiomers where one is a beta adrenergic antagonist and the other acts as a cardiac stimulant without beta adrenergic activity. Treatment with nebivolol leads to a greater decrease in systolic and diastolic blood pressure than [atenolol], [propranolol], or [pindolol]. Nebivolol and other beta blockers are generally not first line therapies as many patients are first treated with thiazide diuretics. Nebivolol was granted FDA approval on 17 December 2007.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Nebivolol {u} (Compound) treats {v} (Disease) hypertension
Nebivolol {u} (Compound) binds {v} (Gene) ADRB2
Nebivolol {u} (Compound) causes {v} (Side Effect) Headache
Nebivolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Magnesium oxide
Nebivolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Magnesium carbonate
Nebivolol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Physostigmine
Nebivolol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Empagliflozin
Nebivolol {u} may lead to a major life threatening interaction when taken with {v} Fingolimod
Nebivolol {u} may lead to a major life threatening interaction when taken with {v} Dyphylline
Nebivolol (Compound) treats hypertension (Disease)
Nebivolol (Compound) binds ADRB2 (Gene)
Nebivolol (Compound) causes Headache (Side Effect)
Nebivolol may cause a minor interaction that can limit clinical effects when taken with Magnesium oxide
Nebivolol may cause a minor interaction that can limit clinical effects when taken with Magnesium carbonate
Nebivolol may cause a moderate interaction that could exacerbate diseases when taken with Physostigmine
Nebivolol may cause a moderate interaction that could exacerbate diseases when taken with Empagliflozin
Nebivolol may lead to a major life threatening interaction when taken with Fingolimod
Nebivolol may lead to a major life threatening interaction when taken with Dyphylline